Centessa Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative medicines to address unmet medical needs

The company's unique asset-centric approach leverages a diverse portfolio of drug candidates, targeting various diseases and conditions, particularly in areas such as oncology, immunology, and rare diseases. Centessa collaborates with leading scientific experts and employs advanced technologies to advance its therapeutic programs through clinical trials, aiming to bring transformative treatments to patients worldwide.